ADAGIO MEDICAL HOLDINGS, INC. Deferred Tax Assets, Operating Loss Carryforwards
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) had Deferred Tax Assets, Operating Loss Carryforwards of $36.66 million as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-27
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $36.66M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $30.45M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $25.79M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $36.66M 10-K · filed 2026-03-27 |
| 2024-12-31 | $30.45M 10-K · filed 2026-03-27 |
| 2023-12-31 | $25.79M 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |